Difference between revisions of "Factor X, human (Coagadex)"
Jump to navigation
Jump to search
(Created page with "==General information== Class/mechanism: Factor X; replaces the missing clotting factor X that is required for hemostasis in patients with inherited or acquired factor X defic...") |
m |
||
| Line 14: | Line 14: | ||
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
[[Category:Fractionated plasma products]] | [[Category:Fractionated plasma products]] | ||
| + | [[Category:Inherited coagulopathy medications]] | ||
[[Category:Hemostasis medications]] | [[Category:Hemostasis medications]] | ||
[[Category:Coagulation factors]] | [[Category:Coagulation factors]] | ||
[[Category:Hematology medications]] | [[Category:Hematology medications]] | ||
Revision as of 14:23, 22 August 2018
General information
Class/mechanism: Factor X; replaces the missing clotting factor X that is required for hemostasis in patients with inherited or acquired factor X deficiency.
Route: IV
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.
Also known as
- Brand name: Coagadex